跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,950 条关于
“complement 3 glomerulopathy”
全部
36,950
临床试验
18,026
药物
4,696
机构
1,357
资讯
12,871
7个月前
Novartis Reports Positive Phase III Results for Fabhalta in Rare Kidney Disease C3 Glomerulopathy
去年
Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
去年
FDA Grants Rare Pediatric Disease Designation to Omeros' Zaltenibart for C3 Glomerulopathy
去年
Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
去年
Omeros' Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy
11个月前
ADARx Pharmaceuticals to Present Phase 1 Data for ADX-038 siRNA Therapy at ASN Kidney Week 2025
去年
ASN Kidney Week 2024: Clinical Trials Highlight Advances in Kidney Disease Treatment
去年
EMA Committee Recommends New Therapies Including Vyjuvek for Rare Skin Disease and Expands Existing Drug Indications
去年
C3G Treatment Landscape Evolves as Novartis and Apellis Near FDA Submissions
去年
Novartis and Apellis Advance C3G Therapies Towards FDA Submission
第 1 页，共 1288 页
上一页
下一页
